Lufen Chang
- Cancer Research top 0.5%
- NF-κB Signaling Pathways 12
- Immunology top 1%
- Immune Response and Inflammation 3
- interferon and immune responses 2
- Molecular Biology top 0.5%
- Melanoma and MAPK Pathways 8
- Cell death mechanisms and regulation 6
- DNA Repair Mechanisms 3
- Cell Biology top 0.5%
- Aging top 2%
-
- Cancer-related Molecular Pathways 8
- Cytokine Signaling Pathways and Interactions 5
- Co-authors
- Michael KarinShin MaedaJiro HirosumiGökhan S. HotamışlıgilGürol TuncmanCem Z. GörgünKazuhisa MaedaK. Teoman Uysal
- Journals
- Journal of Clinical Investigation (3 papers)Proceedings of the National Academy of Sciences (3 papers)Immunity (2 papers)
- Partner nations
- United StatesTaiwanJapan
In The Last Decade
Lufen Chang
27 papers receiving 12.0k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 2.0k
- Immunology 2.3k
- Molecular Biology 7.2k
- Cell Biology 1.2k
- Aging 121
Countries citing papers authored by Lufen Chang
This map shows the geographic impact of Lufen Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lufen Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lufen Chang more than expected).
Fields of papers citing papers by Lufen Chang
This network shows the impact of papers produced by Lufen Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lufen Chang. The network helps show where Lufen Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lufen Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 18 | |
| 2 | 2017 | 32 | |
| 3 | 2013 | 23 | |
| 4 | 2012 | 55 | |
| 5 | 2012 | 32 | |
| 6 | 2011 | 43 | |
| 7 | The E3 Ubiquitin Ligase Itch Couples JNK Activation to TNFα-induced Cell Death by Inducing c-FLIPL Turnoverbreakdown → | 2006 | 582 |
| 8 | Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatasesbreakdown → | 2005 | 1526 |
| 9 | 2003 | 310 | |
| 10 | 2003 | 244 | |
| 11 | A central role for JNK in obesity and insulin resistancebreakdown → | 2002 | 2627 |
| 12 | 2002 | 101 | |
| 13 | 2001 | 49 | |
| 14 | c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritisbreakdown → | 2001 | 691 |
| 15 | Mammalian MAP kinase signalling cascadesbreakdown → | 2001 | 4344 |
| 16 | 2001 | 71 | |
| 17 | 1999 | 294 | |
| 18 | 1996 | 12 | |
| 19 | 1991 | 4 | |
| 20 | 1991 | 7 |
About Lufen Chang
Lufen Chang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 27 papers that have together received 12.2k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (12 papers), Melanoma and MAPK Pathways (8 papers), Cancer-related Molecular Pathways (8 papers), Cell death mechanisms and regulation (6 papers), Cytokine Signaling Pathways and Interactions (5 papers), DNA Repair Mechanisms (3 papers), Immune Response and Inflammation (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (2.0k citations), Immunology (2.3k citations) and Molecular Biology (7.2k citations). Lufen Chang has collaborated with scholars based in United States, Taiwan and Japan. Frequent co-authors include Michael Karin, Shin Maeda, Jiro Hirosumi, Gökhan S. Hotamışlıgil, Gürol Tuncman, Cem Z. Görgün, Kazuhisa Maeda, K. Teoman Uysal, Hideaki Kamata and Shinichi Honda. Their work appears in journals such as Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, Immunity, Cell and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.